Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerstoft

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.
HIV Medicine|March 4, 2024
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohortO Fursa, W Bannister, B Neesgaard, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
HIV Medicine|February 9, 2019
Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDAS Amele, L Peters, M Sluzhynska, et al.
HIV Medicine|March 4, 2024
SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohortO Fursa, W Bannister, B Neesgaard, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analoguesK Van Vaerenbergh, K Van Laethem, J Albert, et al.
Antiviral Therapy|January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testingA M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 20